@article{dfc0ceee65a34995ac1e838abd061199,
title = "Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial",
keywords = "Cardiovascular risk, Hypertension, Spironolactone, Renin, RESISTANT HYPERTENSION, TASK-FORCE, ALDOSTERONISM, PREVENTION, MANAGEMENT, FIBROSIS, IMPACT",
author = "Ferreira, {Jo{\~a}o Pedro} and Timothy Collier and Clark, {Andrew L} and Mamas, {Mamas A} and Rocca, {Hans-Peter Brunner-La} and Stephane Heymans and Arantxa Gonz{\'a}lez and Ahmed, {Fozia Z} and Johannes Petutschnigg and Blerim Mujaj and Joe Cuthbert and Philippe Rouet and Pierpaolo Pellicori and Beatrice Mariottoni and Franco Cosmi and Frank Edelmann and Lutgarde Thijs and Staessen, {Jan A} and Mark Hazebroek and Job Verdonschot and Patrick Rossignol and Nicolas Girerd and Cleland, {John G} and Faiez Zannad",
note = "{\textcopyright} Published on behalf of the European Society of Cardiology. All rights reserved. {\textcopyright} The Author 2021. For permissions, please email: journals.permissions@oup.com.",
year = "2022",
month = feb,
day = "16",
doi = "10.1093/ehjcvp/pvab031",
language = "English",
volume = "8",
pages = "149--156",
journal = "European Heart Journal-Cardiovascular Pharmacotherapy",
issn = "2055-6837",
publisher = "Oxford University Press",
number = "2",
}